BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 21856723)

  • 61. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain.
    Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H
    Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The physiological and pathological biophysics of phase separation and gelation of RNA binding proteins in amyotrophic lateral sclerosis and fronto-temporal lobar degeneration.
    St George-Hyslop P; Lin JQ; Miyashita A; Phillips EC; Qamar S; Randle SJ; Wang G
    Brain Res; 2018 Aug; 1693(Pt A):11-23. PubMed ID: 29723523
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS.
    Ishiguro A; Katayama A; Ishihama A
    FEBS Lett; 2021 Feb; 595(3):310-323. PubMed ID: 33269497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expanding the Phenotype of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FUS).
    Chornenka K; Hirsch-Reinshagen V; Perez-Rosendahl M; Feldman H; Segal-Gidan F; Vinters HV; Mackenzie IR
    J Neuropathol Exp Neurol; 2020 Jul; 79(7):809-812. PubMed ID: 32483606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined fused in sarcoma-positive (FUS+) basophilic inclusion body disease and atypical tauopathy presenting with an amyotrophic lateral sclerosis/motor neurone disease (ALS/MND)-plus phenotype.
    Wharton SB; Verber NS; Wagner BE; Highley JR; Fillingham DJ; Waller R; Strand K; Ince PG; Shaw PJ
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):586-596. PubMed ID: 30659642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
    Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
    Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
    Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration.
    Nakamura M; Bieniek KF; Lin WL; Graff-Radford NR; Murray ME; Castanedes-Casey M; Desaro P; Baker MC; Rutherford NJ; Robertson J; Rademakers R; Dickson DW; Boylan KB
    Acta Neuropathol; 2015 Jul; 130(1):145-57. PubMed ID: 25917047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of FET proteins in neurodegenerative disorders.
    Svetoni F; Frisone P; Paronetto MP
    RNA Biol; 2016 Nov; 13(11):1089-1102. PubMed ID: 27415968
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuron-to-Neuron Transfer of FUS in Drosophila Primary Neuronal Culture Is Enhanced by ALS-Associated Mutations.
    Feuillette S; Delarue M; Riou G; Gaffuri AL; Wu J; Lenkei Z; Boyer O; Frébourg T; Campion D; Lecourtois M
    J Mol Neurosci; 2017 May; 62(1):114-122. PubMed ID: 28429234
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.
    Couthouis J; Hart MP; Erion R; King OD; Diaz Z; Nakaya T; Ibrahim F; Kim HJ; Mojsilovic-Petrovic J; Panossian S; Kim CE; Frackelton EC; Solski JA; Williams KL; Clay-Falcone D; Elman L; McCluskey L; Greene R; Hakonarson H; Kalb RG; Lee VM; Trojanowski JQ; Nicholson GA; Blair IP; Bonini NM; Van Deerlin VM; Mourelatos Z; Shorter J; Gitler AD
    Hum Mol Genet; 2012 Jul; 21(13):2899-911. PubMed ID: 22454397
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chorea as a clinical feature of the basophilic inclusion body disease subtype of fused-in-sarcoma-associated frontotemporal lobar degeneration.
    Kawakami I; Kobayashi Z; Arai T; Yokota O; Nonaka T; Aoki N; Niizato K; Oshima K; Higashi S; Katsuse O; Hosokawa M; Hasegawa M; Akiyama H
    Acta Neuropathol Commun; 2016 Apr; 4():36. PubMed ID: 27044537
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathological features of FTLD-FUS in a Japanese population: analyses of nine cases.
    Kobayashi Z; Kawakami I; Arai T; Yokota O; Tsuchiya K; Kondo H; Shimomura Y; Haga C; Aoki N; Hasegawa M; Hosokawa M; Oshima K; Niizato K; Ishizu H; Terada S; Onaya M; Ikeda M; Oyanagi K; Nakano I; Murayama S; Akiyama H; Mizusawa H
    J Neurol Sci; 2013 Dec; 335(1-2):89-95. PubMed ID: 24050818
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Casein kinase 1δ/ε phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration.
    Kishino Y; Matsukawa K; Matsumoto T; Miyazaki R; Wakabayashi T; Nonaka T; Kametani F; Hasegawa M; Hashimoto T; Iwatsubo T
    J Biol Chem; 2022 Aug; 298(8):102191. PubMed ID: 35753345
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
    Rhine K; Makurath MA; Liu J; Skanchy S; Lopez C; Catalan KF; Ma Y; Fare CM; Shorter J; Ha T; Chemla YR; Myong S
    Mol Cell; 2020 Nov; 80(4):666-681.e8. PubMed ID: 33159856
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TAF15 amyloid filaments in frontotemporal lobar degeneration.
    Tetter S; Arseni D; Murzin AG; Buhidma Y; Peak-Chew SY; Garringer HJ; Newell KL; Vidal R; Apostolova LG; Lashley T; Ghetti B; Ryskeldi-Falcon B
    Nature; 2024 Jan; 625(7994):345-351. PubMed ID: 38057661
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biochemical Properties and Biological Functions of FET Proteins.
    Schwartz JC; Cech TR; Parker RR
    Annu Rev Biochem; 2015; 84():355-79. PubMed ID: 25494299
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.
    Mackenzie IR; Neumann M; Cairns NJ; Munoz DG; Isaacs AM
    J Mol Neurosci; 2011 Nov; 45(3):402-8. PubMed ID: 21603977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.